Most patients reach target dose (8-12mg for retatrutide) by week 16-20 and maintain that dose through week 48 with continued efficacy
The duration for which an individual should remain on tirzepatide for weight loss depends on several factors, including the amount of weight to be lost, individual tolerance to the medication, and the specific health goals you set together with your provider
In this study, a multifunctional dimeric copper peptide incorporated hydrogel, G/D-CuP has been developed as an innovative wound dressing to promote diabetic wound healing
contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Clinicians who anticipate prescribing antibiotics, antivirals, antifungals, or analgesics, or recommending over-the-counter pain relievers to individuals taking any antithrombotic drugs, should consult the agent-specific medication guide or drug information sources for detailed precautions